GliomaGlioblas peptide vaccine (immatics/BioNTech)

N/A

Report date: 2023/06/01 20:00:46

Base Information

Drug NameGliomaGlioblas peptide vaccine (immatics/BioNTech)
Drug Alias NameActively personalized vaccinesAPVAC1APVAC2
ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsDenmarkGermany +[5] 
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlioma Actively Personalized Vaccine Consortium
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmatics Biotechnologies Gmbh
Active IndicationsN/A
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A